These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20724141)

  • 21. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer.
    Aloysius MM; Zaitoun AM; Awad S; Ilyas M; Rowlands BJ; Lobo DN
    Br J Surg; 2010 Aug; 97(8):1269-78. PubMed ID: 20602499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
    Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
    BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reappraisal of a method of reconstruction after pancreatoduodenectomy.
    Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
    Hepatogastroenterology; 2005; 52(64):1077-82. PubMed ID: 16001633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: initial results.
    Henne-Bruns D; Kremer B; Meyer-Pannwitt U; Vogel I; Schröder S
    Hepatogastroenterology; 1993 Apr; 40(2):145-9. PubMed ID: 8099561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?
    Park SJ; Kim SW; Jang JY; Lee KU; Park YH
    World J Surg; 2002 Apr; 26(4):487-92. PubMed ID: 11910485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
    Schwarz RE; Keny H
    Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of 67 pancreatic head tumors and 27 periampullary tumors].
    Nobili P; Annolfi B; Crosta C; Dassi FL; Porretta T; Rovati M
    Ann Ital Chir; 1993; 64(5):505-11. PubMed ID: 7912055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An audit of outcomes of a series of periampullary carcinomas.
    Berberat PO; Künzli BM; Gulbinas A; Ramanauskas T; Kleeff J; Müller MW; Wagner M; Friess H; Büchler MW
    Eur J Surg Oncol; 2009 Feb; 35(2):187-91. PubMed ID: 18343082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA analysis of periampullary cancers.
    Katagiri H; Okayasu I; Endo M
    Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):1-18. PubMed ID: 2225281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors in pancreatic cancer].
    Höfler H
    Chirurg; 1994 Apr; 65(4):253-7. PubMed ID: 8020344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of 150 cases with periampullary carcinoma].
    Wu XD
    Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):296-9. PubMed ID: 7909747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical symptoms in cancer of the exocrine pancreas in peri-ampullary region. Old and new knowledge from the analysis of a surgical patient sample].
    Ridder GJ; Klempnauer J
    Zentralbl Chir; 1996; 121(7):557-64. PubMed ID: 8967195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The curative surgery of periampullary tumors. The results of 48 resections].
    de Almeida JC; Bettencourt A; Costa CS; de Almeida JM
    Acta Med Port; 1995 Jun; 8 Suppl 1():S35-9. PubMed ID: 7653304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
    Sellner FJ; Riegler FM; Machacek E
    Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cancer of the pancreatic head and the periampullary region].
    Bjørnland K; Ofstad E; Hognestad J
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2983-5. PubMed ID: 2237846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of resectable and unresectable periampullary carcinomas.
    Shyr YM; Su CH; Wang HC; Lo SS; Lui WY
    J Am Coll Surg; 1994 Apr; 178(4):369-78. PubMed ID: 7511967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
    Vaidya P; Kawarada Y; Higashiguchi T; Yoshida T; Sakakura T; Yatani R
    J Pathol; 1996 Feb; 178(2):140-5. PubMed ID: 8683379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin expression and its clinical significance in pancreatic cancer.
    Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
    BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.